Drug Approval | October 09, 2022
Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant
The company increases its efficiency and is able to face the growing demand for its services.
The company increases its efficiency and is able to face the growing demand for its services.
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
Campaign to celebrate World Mental Health Day theme "Mental Health in an Unequal World"
Study achieves primary endpoint of radiographic progression-free survival
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
This win is on the back of a prestigious order from Reliance Life Sciences
The inspection concluded with no observation (FDA-483) issued.
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Construction is now underway with the facility scheduled to be operational by 2025
Subscribe To Our Newsletter & Stay Updated
